In early test, Inovio's HIV vaccine delivered immune responses that lasted at least 6 months
Aiming at one of the biggest targets in vaccine development, Inovio reported that its HIV vaccine, Pennvax-GP, induced immune responses that lasted at least six months after vaccination in a phase 1...